Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0440
+0.0020 (4.76%)
Jul 17, 2026, 12:55 PM AEST
Microba Life Sciences Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Microba Life Sciences stock has a consensus rating of "Buy" and an average price target of $0.08. The average 1-year stock price forecast is 81.82% higher than the current stock price, while the lowest is $0.05 (+13.64%) and the highest is $0.12 (+172.73%).
Price Target: $0.08 (+81.82%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Microba Life Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $0.15 → $0.12 | Buy | Maintains | $0.15 → $0.12 | +172.73% | Jul 3, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $0.12 | Buy | Maintains | $0.12 | +172.73% | May 1, 2026 |
Financial Forecast
Revenue This Year
15.49M
from 15.67M
Decreased by -1.16%
Revenue Next Year
19.83M
from 15.49M
Increased by 28.07%
EPS This Year
-0.02
from -0.04
EPS Next Year
-0.01
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.